Literature DB >> 2353150

Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis?

N P Bakker1, M G van Erck, C Zurcher, P Faaber, A Lemmens, M Hazenberg, R E Bontrop, M Jonker.   

Abstract

The induction of experimental arthritis in rhesus monkeys was studied by intradermal immunization of bovine type II collagen and antigens derived from Mycobacterium tuberculosis, Streptococcus pyogenes, and Eubacterium aerofaciens. The tested bacterial antigens proved to be not arthrogenic. Bovine type II collagen induced clinical arthritis in 50% of the rhesus monkeys. Type II collagen induced arthritis in rhesus monkeys proved to be a potential model to study clinical, serological, histological, genetic, and immunologic features associated with human RA.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2353150     DOI： 10.1007/bf02274777

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  31 in total

1.  Clinical and serologic observations in patients with juvenile rheumatoid arthritis and their relatives.

Authors:  A TOUMBIS; E C FRANKLIN; C McEWEN; A G KUTTNER
Journal:  J Pediatr       Date:  1963-04       Impact factor: 4.406

2.  The role of the streptococcus in the pathogenesis of rheumatic fever.

Authors:  F J CATANZARO; C A STETSON; A J MORRIS; R CHAMOVITZ; C H RAMMELKAMP; B L STOLZER; W D PERRY
Journal:  Am J Med       Date:  1954-12       Impact factor: 4.965

3.  Chemical characteristics of the substance of typical amyloidosis in monkeys.

Authors:  E P Benditt; N Eriksen
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1972

4.  Disappearing collagen antibodies in rheumatoid arthritis.

Authors:  R S Pereira; C M Black; V C Duance; V E Jones; R K Jacoby; K I Welsh
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

5.  Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis.

Authors:  R Holmdahl; L Jansson; M Andersson; E Larsson
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

7.  T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones.

Authors:  R Holmdahl; L Klareskog; K Rubin; E Larsson; H Wigzell
Journal:  Scand J Immunol       Date:  1985-09       Impact factor: 3.487

8.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

9.  Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci.

Authors:  W C Watson; A S Townes
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

10.  Induction of arthritis in monkeys by immunization with type II collagen.

Authors:  T J Yoo; S Y Kim; J M Stuart; R A Floyd; G A Olson; M A Cremer; A H Kang
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307
View more
  14 in total

1.  Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys.

Authors:  H P Brok; J M Tekoppele; J Hakimi; J A Kerwin; E M Nijenhuis; C W De Groot; R E Bontrop; B A 't Hart
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.

Authors:  D M Neville; J Scharff; K Srinivasachar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 3.  The value of extended pedigrees for next-generation analysis of complex disease in the rhesus macaque.

Authors:  Amanda Vinson; Kamm Prongay; Betsy Ferguson
Journal:  ILAR J       Date:  2013

4.  Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.

Authors:  S Turner; N P Bakker; B A t Hart; P J Holt; K Morgan
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  RFLP analysis of the HLA-, ChLA-, and RhLA-DQ alpha chain gene regions: conservation of restriction sites during evolution.

Authors:  R E Bontrop; N Otting; L A Broos; M C Noort; M Kenter; M Jonker
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 6.  Prospects of immunotherapy for rheumatoid arthritis.

Authors:  B A t Hart; H G Otten
Journal:  Pharm World Sci       Date:  1995-11-24

7.  Induction of type II collagen-specific antibody production in blood lymphocyte cultures of rhesus monkeys (Macaca mulatta) with collagen-induced arthritis using the immobilized native antigen.

Authors:  B A 't Hart; C A Botman; N P Bakker
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

8.  Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates.

Authors:  Margreet Jonker; Jacqueline Wubben; Krista Haanstra; Michel Vierboom; Bert 't Hart
Journal:  Inflamm Res       Date:  2012-10-13       Impact factor: 4.575

9.  Acquired resistance to type II collagen-induced arthritis in rhesus monkeys is reflected by a T cell low-responsiveness to the antigen.

Authors:  N P Bakker; M G van Erck; L A 't Hart; M Jonker
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  The anti-arthritic and immunosuppressive effects of cyclosporin A on collagen-induced arthritis in the rhesus monkey.

Authors:  N P Bakker; N Van Besouw; R Groenestein; M Jonker; L A Hart
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.